Literature DB >> 8873958

Ischemic heart disease in chronic uremia.

P S Parfrey1, R N Foley.   

Abstract

The burden of ischemic heart disease is high in dialysis patients. Ischemia may result from atherosclerotic and nonatherosclerotic disease and may cause myocardial infarction and angina. The impact of diminished perfusion is intricately associated with the underlying cardiomyopathy, both of which predispose to heart failure. The etiology of ischemia is complex and associated with the underlying cardiomyopathy, whether it be concentric left ventricular hypertrophy, left ventricular dilatation, or systolic dysfunction. Hypertension, diabetes, dyslipidemia, abnormalities of divalent ion metabolism, hypoalbuminemia, and left ventricular hypertrophy are probably adverse risk factors for ischemia, but the relative importance of each is unknown.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873958     DOI: 10.1159/000170280

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

1.  Cardiac function and tolerance to ischemia-reperfusion injury in chronic kidney disease.

Authors:  James M Kuczmarski; Christopher R Martens; Shannon L Lennon-Edwards; David G Edwards
Journal:  Nephrol Dial Transplant       Date:  2013-10-22       Impact factor: 5.992

2.  Cardiac function is preserved following 4 weeks of voluntary wheel running in a rodent model of chronic kidney disease.

Authors:  James M Kuczmarski; Christopher R Martens; Jahyun Kim; Shannon L Lennon-Edwards; David G Edwards
Journal:  J Appl Physiol (1985)       Date:  2014-07-24

3.  Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study.

Authors:  Anna Axelsson Raja; Peder E Warming; Ture L Nielsen; Louis L Plesner; Mads Ersbøll; Morten Dalsgaard; Morten Schou; Casper Rydahl; Lisbet Brandi; Kasper Iversen
Journal:  BMC Nephrol       Date:  2020-09-25       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.